Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites

Parasite Immunology

Volumn 24, Issue 3, 2002, Pages 113-118

  Iniesta, Virginia ^a   Gómez Nieto, L Carlos ^a   Molano, Isabel ^a   Mohedano, Alicia ^b   Carcelén, Jesualdo ^a   Mirón, Cristina ^a   Alonso, Carlos ^c   Corraliza, Inés ^b,d  

^a Parasitology Unit   (Spain)

^b Food Technology   (Spain)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^d UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Arginase; Leishmania; Macrophages; Ornithine; Proliferation

Indexed keywords

N(G) HYDROXYARGININE; ORNITHINE; PUTRESCINE; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HOST CELL; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL;

ANIMALIA; LEISHMANIA MAJOR; MURINAE; PROTOZOA;

EID: 0036243589     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2002.00444.x     Document Type: Article

References (31)

1. Leishmania donovani: Cellular control of ornithine decarboxylase in promastigotes
2. Metabolism and functions of trypanothione in the kinetoplastida
3. 2) in murine bone marrow-derived macrophages
4. Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages
5. Transforming growth factor-β stimulates arginase activity in macrophages
6. Involvement of protein kinase A in the induction of arginase in murine bone marrow-derived macrophages
7. Arginase activity is modulated by IL-4 and Hoarg in nephritic glomeruli and mesangial cells
8. ω-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms
9. L-arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis
10. Antigen presentation by macrophages harboring intravesicular pathogens
11. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis
12. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice
13. Receptor mediated subversion of macrophage cytokine production by intracellular pathogens
14. N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from 1-arginine
15. ω-hydroxy-L-arginine: Implications for the regulation of nitric oxide biosynthesis by arginase
16. ω-hydroxy-L-argininine controls the growth of Leishmania inside macrophages
17. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: Correlation with disease progression in canine experimental leishmaniasis
18. Leishmania parasites and their ploys to disrupt macrophage activation
19. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease
20. IL-4-deficient BALB/c mice resist infection with Leishmania major
21. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection
22. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous Leishmaniasis
23. STAT6-dependent substrate depletion regulates nitric oxide production
24. The role of IL-10 in promoting disease progression in leishmaniasis
25. Transforming growth factor-β in human cutaneous leishmaniasis
26. M-1/M-2 macrophages and the Th1/Th2 paradigm
27. Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice
28. Effects of the new arginase inhibitor N (omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages
29. Substrate specificity of NO synthases: Detailed comparison of 1-arginine, homo-L-arginine, their N omega-hydroxy derivatives and N omega-hydroxy-nor-L-arginine
30. Ornithine decarboxylase gene deletion mutans of Leishmania donovani
31. Therapy and prophylasis of systemic protozoan infections